April 22, 2024
Prochlorperazine Maleate Market

Prochlorperazine Maleate Market in Trends by Growing Demand of Emetics

The Prochlorperazine Maleate market is estimated to be valued at US$ 1.69 Mn in 2024 and is expected to exhibit a CAGR of 3.3% over the forecast period between 2024 to 2030.

Prochlorperazine maleate is commonly used as an emetic to induce vomiting as well as for other medical purposes such as alleviating nausea. It acts as an antidopaminergic agent that blocks dopamine receptors in the chemoreceptor trigger zone of the central nervous system to induce vomiting. The growing demand for effective emetics for symptom relief in various conditions like motion sickness, postoperative nausea, gastroenteritis, and drug overdoses has been a major driver for the prochlorperazine maleate market.

The key players operating in the prochlorperazine maleate market are Polyclean Technologies Inc., Goverdhan Polygran Pvt. Ltd., Nidhi Enterprises, S.S.B Polymers & S.S.B Enterprises, The Shakti Plastic Industries, Dar AI Khaleej Plastics, GRM Polymer, Jai Shree Balaji Plastic, Kamal Polyplast, Mittal Polymers, Nahata Plastics, Navkar Industries, Amruta Plastic, Raza Traders, Vanshika Plastic Industry, Wiwat Plastic, and Xiamen Keyuan Plastic Co., Ltd.

The growing prevalence of conditions requiring nausea and vomiting symptom relief like motion sickness, chemotherapy-induced nausea and vomiting, post-surgical nausea and vomiting, etc. has driven increasing demand for antiemetics like prochlorperazine maleate. Additionally, rising incidents of drug overdoses worldwide also boost the requirement for effective emetics like prochlorperazine maleate to induce vomiting and limit drug absorption in the body.

Manufacturers in the Prochlorperazine Maleate Market Demand are focusing on expanding their operations globally to leverage the potential growing demand. Strategic collaborations and partnerships with regional pharmaceutical players help manufacturers strengthen supply networks and access new emerging markets where demand is rising rapidly. Continuous investments in R&D aim to develop new formulations and dosage forms of prochlorperazine maleate to suit various conditions better.

The key trend being witnessed in the prochlorperazine maleate market involves the development of more convenient delivery methods. This includes new oral fast-dissolving formulations and soluble intravenous preparations that allow for easier and more comfortable administration compared to traditional tablets and injections. Such innovations are expected to boost the popularity of prochlorperazine maleate products in the coming years.

Porter’s Analysis

Threat of new entrants: Low barriers which may lower profitability.

Bargaining power of buyers: Buyers have medium bargaining power given availability of substitutes.

Bargaining power of suppliers: Suppliers have medium bargaining power due to availability of alternatives.

Threat of new substitutes: Threat is medium as there are alternatives available.

Competitive rivalry: Fierce among established players to gain market share.

Geographical Regions

North America accounts for around 40% value share in the prochlorperazine maleate market due to high prevalence and increasing incidence of diseases like schizophrenia and vomiting. The region witnesses high demand owing to widespread awareness and easy accessibility of treatment options.

Asia Pacific exhibits the fastest growth and is expected to witness a CAGR of around 4% during the forecast period. Improving healthcare infrastructure and increasing healthcare expenditure fuel the regional market growth. Rising geriatric population suffering from diseases like schizophrenia further supports market growth.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it